Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

mannitol injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 50 mL Vial Label

50 mL Single-dose Fliptop Vial

25% MANNITOL
Injection, USP
12.5 g/50 mL (250 mg/mL)

For Intravenous Use Only.

WARNING: SEE INSERT REGARDING
CONTRAINDICATION IN SEVERE
RENAL IMPAIRMENT.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 50 mL Vial Label

PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray

50 mL Single-dose Fliptop Vial
25 Units/NDC 0409-4031-01

25% MANNITOL
Injection, USP
12.5 g/50 mL
(250 mg/mL)

Rx only

FOR INTRAVENOUS USE ONLY

Hospira

PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event